Benzinga | Jul 21, 2020 07:27AM EDT

BMO Capital Initiates Coverage On PolyPid with Outperform Rating, Announces Price Target of $30

BMO Capital analyst Gary Nachman initiates coverage on PolyPid (NASDAQ:PYPD) with a Outperform rating and announces Price Target of $30.